本页面由Tiger Trade Technology Pte. Ltd.提供服务

PSYENCE BIOMEDICAL LTD C/WTS 25/01/2029(TO PUR COM)

0.0183
+0.00031.52%
成交量:2,908.00
成交额:52.38
市值:1.30万
市盈率:-0.04
高:0.0183
开:0.0180
低:0.0180
收:0.0180
52周最高:0.0411
52周最低:0.0100
股本:71.32万
流通股本:71.32万
量比:0.28
换手率:0.41%
股息:- -
股息率:- -
每股收益(TTM):-0.5084
净资产收益率:--
总资产收益率:--
市净率:--
市盈率(LYR):- -

数据加载中...

2024/08/19

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/07/31

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/07/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/05/14

SEC问询函

Form CORRESP - Correspondence
2024/05/10

SEC问询函

Form CORRESP - Correspondence
2024/05/10

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/07

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/07

SEC问询函

Form CORRESP - Correspondence
2024/04/18

SEC问询函

Form CORRESP - Correspondence
2024/04/18

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/02/09

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/02/06

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/31

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/01/23

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/01/17

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/11/15

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/11/13

SEC问询函

Form CORRESP - Correspondence
2023/11/03

SEC问询函

Form CORRESP - Correspondence
2023/10/16

SEC问询函

Form CORRESP - Correspondence